RxDoctor Payments Data

Salman Azhar, MD

Neurology · Brooklyn, NYNPI 1952460479

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $20,430 of the $33,160 with a category attached, or 61.6%. Medtronic accounts for 98.2% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $16,443 and has fallen 98.4% since, to $261 in 2025.

$33,160in general payments, 2019–2025

Across 85 payments — averaging $390.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$33K
  • AbbVie$324
  • SPR Therapeutics, Inc$276
$72,528in research payments, 2019–2025

Across 8 payments — averaging $9066.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$41K
  • AstraZeneca$32K

What the payments were for

  • Consulting fees$4,70014%
  • Speaking & faculty fees$20,43062%
  • Travel & lodging$5,43716%
  • Food & beverage$2,5938%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic68$32,560
AbbVie(2 entities)15$324
SPR Therapeutics, Inc2$276

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,160 in reported general payments places this provider in the 85th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Medicare billing

Part B allowed, 2024
$149,842
Medicare patients
345
Services billed
5,656

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PrivigenImmun Glob G(Igg)/Pro/Iga 0-5014$270,830
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5014$252,893
Gamunex-CImmune Globul G/Gly/Iga Avg 4612$88,374
EliquisApixaban19$15,177
Memantine Hcl25$631
Levetiracetam15$376
Rosuvastatin Calcium21$367
Duloxetine Hcl24$276
Olanzapine11$224
Atorvastatin Calcium27$190
Gabapentin29$170
Donepezil Hcl19$144
Sertraline Hcl12$55
Topiramate14$47

Paid to pharmacies, not to this prescriber.

Other neurology in Brooklyn

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →